FDA expands approval of Mavyret for treatment of HCV and cirrhosis
Mavyret marks the first eight-week treatment approved for patients with HCV genotypes 1-6 both without cirrhosis and with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
27 Sep 19
Mavyret marks the first eight-week treatment approved for patients with HCV genotypes 1-6 both without cirrhosis and with…
25 Sep 19
Pfizer and Flatiron Health have expanded collaboration to jointly work on integrating real-world evidence for breast cancer medicines
19 Sep 19
Lupus nephritis is an autoimmune disease condition of systemic lupus erythematosus (SLE), where the patient’s own immune system…
17 Sep 19
The integration of technologies enables people with diabetes and their caregivers to track the insulin dosing data and…
16 Sep 19
cobas pro integrated solutions is designed to improve productivity, enhance reliability in the lab and time taken for…
13 Sep 19
Nucala is the only targeted biologic in the US to receive FDA approval for treating eosinophilic asthma in…
09 Sep 19
The centre is set to nurture innovation by bringing together local and international companies, government, and medical and…
03 Sep 19
CHEPLAPHARM has selected Clinigen to distribute Etopophos and Vepesid in Australia and New Zealand as part of its…
25 Jun 19
The British Liver Trust is calling for urgent action as figures in their new report, ‘The Alarming Rise…
28 May 19
In light of new data which demonstrates that the cases of mumps has tripled in the first quarter…